Watching ImmunityBio, Inc.? See every signal: funding, hires, M&A, contracts, sentiment.
Book a demoChoose your planImmunityBio, Inc.
nantkwest.comAI Executive Summary
AI-powered analysis of 8-K filing content
ImmunityBio announced Q2 2026 financial results and a business update on August 4, 2026, providing investors with an overview of the company's operational and financial position as of June 30, 2026.
Key Takeaways
Company released Q2 2026 financial results covering the three and six months ended June 30, 2026
Business update includes operational insights and financial position assessment as of mid-year 2026
2 more takeaways
Filing Overview
What This Means
ImmunityBio, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.